Cargando…
Marketed drugs used for the management of hypercholesterolemia as anticancer armament
The design of novel pharmacologic agents as well as their approval for sale in markets all over the world is a tedious and pricey process. Inevitably, oncologic patients commonly experience unwanted effects of new anticancer drugs, while the acquisition of clinical experience for these drugs is larg...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598753/ https://www.ncbi.nlm.nih.gov/pubmed/28932124 http://dx.doi.org/10.2147/OTT.S140483 |